Together, these results revealed a novel post-transcriptional regulatory mechanism for ERManI and implied that this molecule contributes to the regulation of carcinogenesis in HCC independent of its function in glycoprotein quality control. The gene discussed is MAN1B1; the disease is hepatocellular carcinoma.